Condition
    Moderate Evidence
    Effectiveness 2/5

    Berberine for Ovarian Cysts

    Berberine has trial evidence for the insulin-resistance and ovulation irregularity behind PCOS-type cyst patterns — but no supplement shrinks an existing cyst, and most functional cysts need nothing but time.

    Overview

    Berberine has trial evidence for the insulin-resistance and ovulation irregularity behind PCOS-type cyst patterns — but no supplement shrinks an existing cyst, and most functional cysts need nothing but time.

    Verdict

    Mixed evidence

    How It Works

    Berberine activates AMPK, improving insulin sensitivity and reducing the hyperinsulinaemia that drives ovarian androgen production — the hormonal engine behind polycystic ovary patterns. Lower insulin and androgen levels allow more regular ovulation.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500 mg two to three times daily with meals
    Expected timeframe
    3-6 months for cycle and metabolic changes

    Protocol

    form
    Berberine hydrochloride
    step 1
    Confirm the diagnosis - PCOS-related follicles and a true ovarian cyst are different problems, and only the former is what these trials studied
    timing
    With meals
    duration
    3-6 months - cycle regularity needs several cycles to assess
    titration
    Build to 500 mg three times daily (1.5 g/day), the dose used in the Chinese comparative trials
    measurement
    Cycle length and regularity, fasting insulin and HOMA-IR at baseline and 3 months
    starting dose
    500 mg with the largest meal for week one

    Evidence

    What the studies say

    Chinese randomised trials comparing berberine (roughly 1.5 g daily) with metformin in PCOS found comparable improvements in insulin resistance, cycle regularity, and ovulation rates, with a meta-analysis supporting benefit — though trial quality is moderate and blinding often weak. No trial examines cyst resolution as an endpoint. For simple functional cysts, expectant management remains the evidence-based standard.

    Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis

    Score: 8/10
    2021
    meta_analysis
    n=1079

    Zhao H, et al.

    Myo-inositol combined with D-chiro-inositol and metformin combined with thiazolidinediones appear superior to metformin alone in improving insulin resistance and decreasing total testosterone. Myo-inositol combined with D-chiro-inositol is particularly efficacious in menstrual recovery.

    View source

    Safety

    Caveats

    GI upset is common initially; start low. Avoid in pregnancy. Interacts with metformin and cyclosporine. Never a substitute for gynaecological review of persistent or complex cysts.

    Less likely to help if

    Women with lean PCOS or non-insulin-resistant phenotypes, and anyone with a structural ovarian cyst needing gynaecological assessment.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.